The rise of Viagra and its influence on the medicinal landscape presents a complicated question for shareholders. While the initial sales statistics were remarkable, the exclusivity has lapsed, leading to a deluge of https://kathrynztny455390.imblogs.net/91241528/the-blue-pill-and-big-pharma-a-speculative-opportunity